Equities
Health CareHealth Care Providers
  • Price (HKD)4.47
  • Today's Change-0.98 / -17.98%
  • Shares traded60.89m
  • 1 Year change-2.40%
  • Beta1.2761
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Yidu Tech Inc is a China-based investment holding company that mainly provides medical big data solutions. The Company operates through three segments. The Big Data Platform and Solutions segment is mainly composed of big data platform offerings and other solutions to customers. The Life Science Solutions segment is responsible for providing analysis-driven clinical development, real-world evidence (RWE)-based research, and digital commercialization solutions to pharmaceutical, biotech and medical device companies and other companies. The Health Management Platform and Solutions segment mainly operates research-driven personal health management platforms and provides insurance technology and disease management solutions to insurance companies and agencies. The Company's main data intelligence infrastructure is YiduCore.

  • Revenue in HKD (TTM)866.96m
  • Net income in HKD-209.41m
  • Incorporated2014
  • Employees902.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
IVD Medical Holding Ltd3.29bn279.77m2.89bn815.008.600.66148.990.87890.20690.20692.442.690.62022.186.954,099,518.005.285.187.446.6722.6720.758.517.531.287.490.1926--12.3549.4913.4118.1519.77--
Modern Dental Group Ltd3.27bn408.15m3.36bn7.18k8.271.246.141.030.4290.4293.442.850.84719.385.14465,149.5010.527.0512.358.3453.4050.7712.419.242.5810.750.240539.9812.086.5083.3036.462.42--
OrbusNeich Medical Group Holdings Ltd1.18bn301.36m3.45bn1.28k11.501.1910.182.930.36270.36271.423.500.38391.154.20943,274.209.83--10.63--68.71--25.61--8.32--0.0214--12.45--143.76------
China Isotope & Radiation Corp7.20bn428.14m3.51bn3.13k8.200.68913.160.48771.341.3422.5215.930.5253.371.802,319,527.006.266.5712.8513.2651.6359.8911.9212.621.6757.070.218728.277.8215.35-5.432.883.632.89
Zylox-Tonbridge Medical Technolgy Co Ltd712.85m27.55m3.60bn756.00130.751.0755.625.060.08410.08412.1810.290.19571.16473.84931,828.600.7561--0.8234--71.62--3.86--3.38--0.0255--57.97--30.66------
Shanghai INT Medical Instruments Co Ltd865.15m189.59m4.95bn1.73k24.972.7419.135.721.131.135.1110.250.41282.0812.01552,105.408.818.6310.419.7660.1659.4421.3426.162.06--0.038431.8028.5029.9618.7921.7645.75--
MicroPort NeuroScientic Corp832.13m241.71m5.41bn534.0022.502.9718.496.500.41550.41551.433.150.38991.178.301,457,322.0010.91--12.61--74.12--27.97--4.53--0.0282--21.61--768.73------
AK Medical Holdings Ltd1.18bn202.79m5.64bn974.0027.682.1118.944.760.18140.18141.062.380.35140.75731.971,125,532.006.029.277.4611.2860.9165.0617.1321.782.58--0.04822.653.9712.74-11.074.6721.675.88
Yidu Tech Inc866.96m-209.41m5.76bn902.00--1.34--6.64-0.1991-0.19910.82444.070.1658114.901.36961,148.50-4.54-35.96-5.35-51.3842.0634.80-27.41-159.716.77--0.0227--0.295351.2368.96---2.99--
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd439.41m231.67m5.99bn239.0025.862.9724.5913.640.66810.66811.275.830.20250.64037.162,006,447.0010.68--11.59--89.26--52.72--5.34--0.0014--31.58--864.81------
Shanghai Conant Optical Co Ltd2.05bn405.16m6.07bn2.76k14.843.8812.952.970.95940.95944.843.670.93532.325.94815,548.5018.5212.5725.2718.6938.3735.2719.8014.641.70--0.130418.5712.7015.5631.5633.0413.49--
New Horizon Health Ltd1.46bn118.83m6.47bn1.04k59.472.0241.834.420.23780.23783.207.010.45362.162.081,666,325.003.67--3.99--88.74--8.10--10.50--0.1305--259.54--97.40------
LifeTech Scientific Corp1.38bn267.08m6.85bn1.41k24.611.8641.934.980.06010.06010.31110.7940.28770.6179.19951,249.001.817.092.168.5178.5879.666.3022.692.02--0.16350.0015.4817.88-19.0916.8026.11--
Kangji Medical Holdings Ltd1.05bn574.06m7.09bn964.0011.952.8012.466.730.49030.49030.89992.090.2291.835.071,050,468.0011.6414.4016.9016.1879.7881.7550.8457.241.74--0.0031111.8117.7621.235.2828.0041.50--
Data as of Nov 22 2024. Currency figures normalised to Yidu Tech Inc's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

18.94%Per cent of shares held by top holders
HolderShares% Held
Sunshine Life Insurance Co. Ltd. (Investment Portfolio)as of 31 Mar 202496.07m9.05%
Brunei Investment Agency (Investment Management)as of 06 Jun 202465.13m6.13%
The Vanguard Group, Inc.as of 06 Nov 202421.66m2.04%
BlackRock Fund Advisorsas of 07 Nov 20246.70m0.63%
Bosera Asset Management Co., Ltd.as of 30 Jun 20244.69m0.44%
BlackRock Advisors (UK) Ltd.as of 08 Nov 20242.24m0.21%
Guotai Asset Management Co., Ltd.as of 30 Jun 20241.83m0.17%
Bellevue Asset Management AGas of 30 Aug 20241.55m0.15%
Vanguard Fiduciary Trust Co.as of 31 Aug 2024676.30k0.06%
Norges Bank Investment Managementas of 30 Jun 2024604.80k0.06%
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.